Medical News
Research Finds Viable Marker for the Early Diagnosis of Most Common Type of Pancreatic Cancer
Teams of researchers from Spain have identified a new viable marker for early diagnosis in the most common type of pancreatic cancer, pancreatic du...
New Programme ‘LEA’ Helps Patients and Physicians on Topic of Metastatic Digestive Cancers
New website offers resources for patients and physicians on the topic of metastatic digestive cancers
...
The EC Approves Nivolumab Plus Chemotherapy as First Line Treatment for Oesophageal Cancer
European Commission approves nivolumab plus chemotherapy as first line treatment for oesophageal cancer
...
Raising Awareness of Pancreatic Cancer on November 18
Join us on November 18 to raise awareness of pancreatic cancer on World Pancreatic Cancer Day
...
Ensuring the Patient Voice in Research – Irish Initiative Shows the Way
Irish study demonstrates a successful collaboration between patients and researchers
...
Update in Science Masterclass Explores Personalising Treatment Strategies in Digestive Cancers
Update in Science Masterclass Explores Personalising Treatment Strategies in Digestive Cancers
...
Immunotherapy Drug Combination for Treating Metastatic Colorectal Cancer Approved in the EU
Nivolumab & ipilumab combination approved by the EC for MSI-H or dMMR patients with mCRC broadens treatment options
...
European Network Works to Better Quality of Life for CCA Patients
European Network works to better the quality of life of patients with the rare digestive cancer – CCA
...
EMA Approves New Treatment Option for Certain Cholangiocarcinoma Patients
Rare Digestive Cancers – EMA Approval of New Treatment Option for Certain Cholangiocarcinoma Patients
...
Nivolumab prolongs disease-free survival in patients with resected oesophageal cancer
New study shows nivolumab prolongs disease-free survival in patients with resected oesophageal cancer
...